{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-09-09T12:23:47.450119+00:00",
  "news": [
    {
      "title": "2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5\" target=\"_blank\">2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-09-08T13:02:54+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals - Pharmaceutical Executive",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb0JfakZLeGZIazVnZHYzNjZ2UGJpME5DRUxtS1F0d09HZWVOMFhwQkhxMmRpbFh2T2IxSjQwZDZfTHdNNnlDNTZmN0ppeU5abUtoVW5TbGtRVTVaY3RmTHNjWFBIbWtJVXlPOUtzRHZEbXRfM2ducE1TMGRTX0dGMUtuM05EeERPb2p3U0N5OHhzaktTaTQxRTlUc1hncEtzYUZZUUI2SnY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb0JfakZLeGZIazVnZHYzNjZ2UGJpME5DRUxtS1F0d09HZWVOMFhwQkhxMmRpbFh2T2IxSjQwZDZfTHdNNnlDNTZmN0ppeU5abUtoVW5TbGtRVTVaY3RmTHNjWFBIbWtJVXlPOUtzRHZEbXRfM2ducE1TMGRTX0dGMUtuM05EeERPb2p3U0N5OHhzaktTaTQxRTlUc1hncEtzYUZZUUI2SnY?oc=5\" target=\"_blank\">Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaceutical Executive</font>",
      "published": "2025-09-03T18:12:36+00:00",
      "source": "Pharmaceutical Executive"
    },
    {
      "title": "Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals - Wilson Sonsini",
      "link": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPUnRWS3FTUnJDQ2V6bDVjcFQ5R1Q5aE1aUy1lNXRLQk5TbWVlYU9xcGRjWUdCUmNpUWY2MEN4ZHA0QmJPR1BVU0RObEUyanNqdmFuQzNBa2YtNFN1SG5mNEZ5ZkZCYzYwMklVVnA4WFpiWmcyMkxvUTNubW1GaFd2QVdUVko3T0l3ekFTd1RJOWZPNkVJOE0xV3hha0NzRC1pYUZDZFdqMy1yNlFyUEhuNTU3NmxnU1AyZzFZLTJTTnBBZWdWTEVMTTROQnl5NTRkM2Y4djZaY1RDdU9oZm9OTlU1eUh5dGs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPUnRWS3FTUnJDQ2V6bDVjcFQ5R1Q5aE1aUy1lNXRLQk5TbWVlYU9xcGRjWUdCUmNpUWY2MEN4ZHA0QmJPR1BVU0RObEUyanNqdmFuQzNBa2YtNFN1SG5mNEZ5ZkZCYzYwMklVVnA4WFpiWmcyMkxvUTNubW1GaFd2QVdUVko3T0l3ekFTd1RJOWZPNkVJOE0xV3hha0NzRC1pYUZDZFdqMy1yNlFyUEhuNTU3NmxnU1AyZzFZLTJTTnBBZWdWTEVMTTROQnl5NTRkM2Y4djZaY1RDdU9oZm9OTlU1eUh5dGs?oc=5\" target=\"_blank\">Firm Advises Enlaza on IP Matters Related to Multi-Target Drug Discovery Collaboration with Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Wilson Sonsini</font>",
      "published": "2025-09-05T20:43:20+00:00",
      "source": "Wilson Sonsini"
    },
    {
      "title": "What's Wrong With Vertex Pharmaceuticals Stock? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQV1g2UTlYQ2VFVUQybnItNDVkZTdTQ08xdlZTZjVrN2hhZkIxckEwcFd0dTQzWUxzMFdjT2tXVjdoQXhZcDczMmpiZ3B3NXptRmpLVmw5TUtMbG5XYU9SdFVkR0ZlTWZMcUs2NVphNGVQeDU4a3FiZFFnWVBqaDN0Q0M4dWZxbWVEMzFhR20tY21TZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQV1g2UTlYQ2VFVUQybnItNDVkZTdTQ08xdlZTZjVrN2hhZkIxckEwcFd0dTQzWUxzMFdjT2tXVjdoQXhZcDczMmpiZ3B3NXptRmpLVmw5TUtMbG5XYU9SdFVkR0ZlTWZMcUs2NVphNGVQeDU4a3FiZFFnWVBqaDN0Q0M4dWZxbWVEMzFhR20tY21TZw?oc=5\" target=\"_blank\">What's Wrong With Vertex Pharmaceuticals Stock?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-08-20T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Is Vertex Pharmaceuticals Stock Underperforming the S&P 500? - MSN",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNeEVISk84NGVDbW00ZFJrbktVazVpS3hMaWl4RFpMRU14b185X2NuNGY3Rkg2QjM3U2FYU29tcGo2eGx2U3h2djVBcVRjazhsRGJJWXYtcWd5MVZYY0pEQ2QtVmZPX0hTNm1scWhpenBvWmNtc01Od0Y1cDd6MmRScWpPNGsybldxZ0xIa1FSUEpsOU1wTm1reTY3OXhqa2YzRkF6TVhGeUZCVEY4YVJQSw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNeEVISk84NGVDbW00ZFJrbktVazVpS3hMaWl4RFpMRU14b185X2NuNGY3Rkg2QjM3U2FYU29tcGo2eGx2U3h2djVBcVRjazhsRGJJWXYtcWd5MVZYY0pEQ2QtVmZPX0hTNm1scWhpenBvWmNtc01Od0Y1cDd6MmRScWpPNGsybldxZ0xIa1FSUEpsOU1wTm1reTY3OXhqa2YzRkF6TVhGeUZCVEY4YVJQSw?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals Stock Underperforming the S&amp;P 500?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-09-08T13:49:43+00:00",
      "source": "MSN"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOYzBDRmh0NjB4cnNQdkRzUXg1NGtzR1VXeGhpV2RXTVd0VTE2MzJvMXBqc0l2eVk0Q0o1WEFEbjJMMGRIOXJPeWk2M2VGZkNQMUxTMWdHckNOUThtaHQzWkJGSVNYVndoR0JvaFNfdmRzTzlmcllOSG1XY2ducUgtZE9ocEh2UXBiaFRrVA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxOYzBDRmh0NjB4cnNQdkRzUXg1NGtzR1VXeGhpV2RXTVd0VTE2MzJvMXBqc0l2eVk0Q0o1WEFEbjJMMGRIOXJPeWk2M2VGZkNQMUxTMWdHckNOUThtaHQzWkJGSVNYVndoR0JvaFNfdmRzTzlmcllOSG1XY2ducUgtZE9ocEh2UXBiaFRrVA?oc=5\" target=\"_blank\">Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-03T12:17:25+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharma CEO Buys the Stock Dip - Barron's",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5\" target=\"_blank\">Vertex Pharma CEO Buys the Stock Dip</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-08-15T07:00:00+00:00",
      "source": "Barron's"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth and Strategic Positioning Justify Buy Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOU3g4MEc1a2FVWm84OERBUHJiVy11VDRfN1NRQ05Jb3lIXzNvSmZfOGY5a19YQW9nU2hJSjR6M2RYXzVGb3U1VzBKNW9PaGwydVhXc1E4VE5yOHR2ZVRGT3FiRG5xRXJKQmktRWt5bThPU2NWR2xCNEF3UWljYmNCMmtlcDRDdHRqRDliWUM2ek1MSFVGQTJCZ1FFbnpMS0xGdUE0TUVhR0d5R1BycHVLbWdWajUzNUVfWlFPOXZ6RDBzR1dHbHlTbkRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxOU3g4MEc1a2FVWm84OERBUHJiVy11VDRfN1NRQ05Jb3lIXzNvSmZfOGY5a19YQW9nU2hJSjR6M2RYXzVGb3U1VzBKNW9PaGwydVhXc1E4VE5yOHR2ZVRGT3FiRG5xRXJKQmktRWt5bThPU2NWR2xCNEF3UWljYmNCMmtlcDRDdHRqRDliWUM2ek1MSFVGQTJCZ1FFbnpMS0xGdUE0TUVhR0d5R1BycHVLbWdWajUzNUVfWlFPOXZ6RDBzR1dHbHlTbkRR?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth and Strategic Positioning Justify Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-09-08T15:01:39+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5\" target=\"_blank\">Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-02-11T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-09-08",
      "close": 395.25
    },
    "history": [
      {
        "date": "2025-08-28",
        "close": 392.04998779296875
      },
      {
        "date": "2025-08-29",
        "close": 391.0199890136719
      },
      {
        "date": "2025-09-02",
        "close": 401.0
      },
      {
        "date": "2025-09-03",
        "close": 396.6199951171875
      },
      {
        "date": "2025-09-04",
        "close": 396.92999267578125
      },
      {
        "date": "2025-09-05",
        "close": 396.1199951171875
      },
      {
        "date": "2025-09-08",
        "close": 395.25
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}